Abstract
Prostate cancer is the most commonly diagnosed cancer in men in Europe and Northern America. Genome-wide association studies (GWAS) have detected an association with markers on chromosome 8q24. Allele -8 of microsatellite DG8S737 with 22 repeats and allele A of the single-nucleotide polymorphism (SNP) rs1447295 have been found to be significantly associated with prostate cancer. As GWAS are subjected to type 1 error, confirmation studies are required to validate the results. Here, we analysed the same markers in 277 cases and 282 controls from the Netherlands using a nested case–control study. Incident prostate cancer cases and controls selected were identified in the population of the Netherlands Cohort Study. We also investigated clinical features of the disease by stratifying by tumour stage. We did not replicate the association with the SNP rs1447295-A allele (P=0.10), although the effect estimate was in the same direction as previous studies (odds ratio (OR), 1.38). Interestingly a statistically significant decreased risk was observed for DG8S737 allele -8 (OR, 0.62; P=0.03). The apparent protective effect of the DG8S737 -8 allele observed in this study contrasts with the Amundadottir study. This suggests that DG8S737 and rs1447295 might be tightly linked markers flanking the actual causative variant and that there may be potentially more than one high-risk haplotype present in the Caucasian population. This short report highlights the importance of validation, although further confirmation is still needed.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ : Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225–249.
Amundadottir LT, Sulem P, Gudmundsson J et al: A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38: 652–658.
Suuriniemi M, Agalliu I, Schaid DJ et al: Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 2007; 16: 809–814.
Yeager M, Orr N, Hayes RB et al: Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645–649.
Gudmundsson J, Sulem P, Manolescu A et al: Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39: 631–637.
Zeegers MP, van Poppel F, Vlietinck R, Spruijt L, Ostrer H : Founder mutations among the Dutch. Eur J Hum Genet 2004; 12: 591–600.
van den Brandt PA, Goldbohm RA, van 't Veer P, Volovics A, Hermus RJ, Sturmans F : A large-scale prospective cohort study on diet and cancer in the Netherlands. J Clin Epidemiol 1990; 43: 285–295.
Sobin LH, Fleming ID : TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803–1804.
Ebrahim S, Davey Smith G : Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet 2008; 123: 15–33.
Sarkar NKV : Genetic diversity at two pentanucleotide STR and thirteen tetranucleotide STR loci by multiplex PCR in four predominant population groups of central India. Forensic Science International 2002; 128: 196–201.
Pritchard JK SM, Stephens M, Donnelly P : Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945–959.
Wang L, McDonnell SK, Slusser JP et al: Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 2007; 67: 2944–2950.
Acknowledgements
This study was established with financial support from the Dutch Cancer Society and the US Department of Defense.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Zeegers, M., Khan, H., Schouten, L. et al. Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variant. Eur J Hum Genet 19, 118–120 (2011). https://doi.org/10.1038/ejhg.2010.133
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2010.133
Keywords
This article is cited by
-
Association of three 8q24 polymorphisms with prostate cancer susceptibility: evidence from a meta-analysis with 50,854 subjects
Scientific Reports (2015)
-
Characterization of 14 novel deletions underlying Rubinstein–Taybi syndrome: an update of the CREBBP deletion repertoire
Human Genetics (2015)
-
Genetic variation at 8q24, family history of cancer, and upper gastrointestinal cancers in a Chinese population
Familial Cancer (2014)
-
Prostate cancer susceptibility genes on 8p21–23 in a Dutch population
Prostate Cancer and Prostatic Diseases (2013)
-
Diffusion tensor imaging and fiber tractography in brain malformations
Pediatric Radiology (2013)
